Core Insights - BTL's flagship device, EMSCULPT NEO, plays a crucial role in astronaut training for the upcoming mission to the International Space Station (ISS) [1][3] - The device is integrated into a comprehensive training program aimed at enhancing endurance, strength, balance, and recovery for astronaut Tibor Kapu [3][4] - EMSCULPT NEO is recognized for its ability to combat muscle mass loss, which can reach up to 30% during space missions, according to research [3] Company Overview - BTL, established in 1993, is a global leader in medical technology, providing innovative solutions across various fields including dermatology, plastic surgery, and rehabilitation [5] - The company holds over 200 patents and employs more than 600 engineers, focusing on advancing medical treatments through technology and science [5] - BTL's product portfolio includes EMSCULPT NEO, EMFACE, EXION, EXOMIND, and EMSELLA, among others [5]
BTL的EMSCULPT NEO助力匈牙利宇航员进行国际太空任务训练
Huan Qiu Wang Zi Xun·2025-10-23 03:55